Accéder au contenu
Merck
Toutes les photos(1)

Documents

H-081

Supelco

7-Hydroxyquetiapine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule empirique (notation de Hill):
C21H25N3O3S
Numéro CAS:
Poids moléculaire :
399.51
Numéro MDL:
Code UNSPSC :
41116107
ID de substance PubChem :
Nomenclature NACRES :
NA.24

Qualité

certified reference material

Niveau de qualité

Forme

liquid

Caractéristiques

Snap-N-Spike®/Snap-N-Shoot®

Conditionnement

ampule of 1 mL

Fabricant/nom de marque

Cerilliant®

Concentration

1.0 mg/mL in methanol

Technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

Application(s)

clinical testing

Format

single component solution

Température de stockage

−20°C

Chaîne SMILES 

OCCOCCN1CCN(C2=NC(C=CC(O)=C3)=C3SC4=C2C=CC=C4)CC1

InChI

1S/C21H25N3O3S/c25-12-14-27-13-11-23-7-9-24(10-8-23)21-17-3-1-2-4-19(17)28-20-15-16(26)5-6-18(20)22-21/h1-6,15,25-26H,7-14H2

Clé InChI

VEGVCHRFYPFJFO-UHFFFAOYSA-N

Description générale

A Certified Solution Standard for the primary active metabolite of quetiapine, marketed as the atypical antipsychotic Seroquel® for the treatment of depression, bipolar disorder, and schizophrenia. This new reference standard is suitable for a variety of GCMS and LCMS applications from forensic and forensic toxicology analyisis to urine drug testing. We also offer certified Snap-N-Shoot® solutions of the parent drug Quetiapine fumarate (Q-001) and the internal standard Quetiapine-D8 hemifumarate (Q-002) as well as a wide selection of other atypical antipsychotics and their metabolites and internal standards, such as aripiprazole, clozapine, risperidone, olanzapine, and ziprasidone.

Application


  • Metabolic Analysis of Quetiapine and 7-Hydroxyquetiapine: Research outlined a liquid chromatographic-mass spectrometric procedure specifically developed for analyzing 7-Hydroxyquetiapine alongside quetiapine, validating the method through its application in rat brain and blood samples. This study emphasizes the value of 7-Hydroxyquetiapine in understanding the pharmacokinetics of antipsychotic treatments, crucial for drug metabolism research and therapeutic monitoring (Heisel et al., 2024).

  • Drug Entry and Retention in Hair: An investigative study focused on the distribution of Quetiapine and 7-Hydroxyquetiapine in guinea pig hair roots and shafts post-repeated administration. This work contributes to forensic toxicology by exploring how antipsychotic drugs and their metabolites interact with and are retained in hair, providing insights that support legal and medical inquiries into drug use history (Ji et al., 2021).

  • Single Dose Metabolite Tracking: Research examined the characteristics of quetiapine and 7-Hydroxyquetiapine in hair roots and blood after a single dose, offering a detailed look at the acute phase of metabolite processing in the body. This study aids in forensic analysis and may contribute to better understanding the immediate metabolic responses to quetiapine in clinical scenarios (Yan et al., 2020).

Informations légales

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Seroquel is a registered trademark of Astrazeneca UK
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictogrammes

FlameSkull and crossbonesHealth hazard

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

Organes cibles

Eyes

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

49.5 °F - closed cup

Point d'éclair (°C)

9.7 °C - closed cup


Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

R H Pullen et al.
Journal of chromatography, 573(1), 49-57 (1992-01-03)
ICI 204,636 (I) is an orally active antipsychotic agent under development for the treatment of schizophrenia in humans. It is partially converted in animals to an active 7-hydroxy metabolite (II). Methods were developed for the simultaneous determination of both analytes

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique